Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Robert Michael Duvoisin
Introduction: Robert Michael Duvoisin, an esteemed inventor based in Astoria, NY, has made significant strides in the field of neuroscience through his innovative work on neuronal nicotinic acetylcholine receptors. His passion for advancing medical science is marked by his singular but impactful patent, which enhances our understanding of these crucial receptors.
Latest Patents: Duvoisin holds a patent for the invention titled "Recombinantly produced .beta.4 neuronal nicotinic acetylcholine receptor." This groundbreaking invention discloses a novel subunit of the neuronal nicotinic acetylcholine receptor—.beta.4. The .beta.4 subunit can form functional combinations with other receptor subunits, such as alpha2, alpha3, alpha4, and beta2, thereby expanding the potential for therapeutic applications. To protect his invention, a cDNA clone containing the DNA sequences that encode this new receptor subunit has been deposited with the American Type Culture Collection.
Career Highlights: Throughout his career, Duvoisin has demonstrated a commitment to advancing research in neurosciences. His patent not only signifies a personal achievement but also contributes significantly to the body of knowledge in receptor biology, with implications for understanding neuropharmacology and developing treatments for various neurological conditions.
Collaborations: Duvoisin has collaborated with notable experts in the field, including Stephen Fox Heinemann and Evan Samuel Deneris. These collaborations have fostered a rich exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion: Robert Michael Duvoisin’s contributions to the field of neuroscience, particularly with his patent on the .beta.4 neuronal nicotinic acetylcholine receptor, underscore the importance of innovation in understanding complex biological systems. His work not only paves the way for future research but also serves as an inspiration for aspiring inventors and researchers in the scientific community.